News

Filter

Positive results with Portola’s anti-clotting agent andexanet alfa and Eliquis

Positive results with Portola’s anti-clotting agent andexanet alfa and Eliquis

01-10-2014

Portola Pharmaceuticals says that its first Phase III study of andexanet alfa, a potential universal…

andexanet alfaBayerBristol-Myers SquibbCardio-vascularedoxabanEliquisJanssenPfizerPharmaceuticalPortola PharmaceuticalsRegulationResearchUSAXarelto

“Breakthrough Therapy” status for Portola’s andexanet alfa

25-11-2013

USA-based Portola Pharmaceuticals has been granted “Breakthrough Therapy” designation by the US Food…

andexanet alfaBayerBristol-Myers SquibbCardio-vascularEliquisNorth AmericaPharmaceuticalPortola PharmaceuticalsRegulationResearchXarelto

Back to top